Recombinant mutant human tumor necrosis factor alpha (State Key Laboratory of Cancer Biology)

N/A

Report date: 2022/02/09 09:59:44

Base Information

Drug NameRecombinant mutant human tumor necrosis factor alpha (State Key Laboratory of Cancer Biology)
Drug Alias NamermhTNF-alpha重组突变型人肿瘤坏死因子α
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionTumor necrosis factor receptor agonists
TargetsTumor necrosis factor receptor
Therapy Area/IndicationsLung NeoplasmsHead and Neck NeoplasmsStomach Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesState Key Laboratory Of Cancer Biology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesState Key Laboratory Of Cancer Biology
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsHead and Neck NeoplasmsStomach Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A